Mauro Giacca, MD PhD, is Head of the School of Cardiovascular and Metabolic Medicine&Sciences at King’s College London. Until 2019, he has served as Director-General of the ICGEB, a United Nations organization. Since 2005, he is Full Professor of Molecular Biology at the University of Trieste, Italy. Prof Giacca is considered an expert in gene and RNA therapy for cardiovascular disorders. He leads a recently established MRC/BHF Centre for Cardiac Repair and Regeneration (REACT) and is Co-Director of the BHF Centre of Research Excellence at King’s. His research is funded internationally, including three consecutive ERC Advanced grants and 2 consecutive Leducq Foundation grants, and a BHF Programme grant. Prof Giacca is a Fellow of the Academy of Medical Sciences, UK and is the past-president of the International Society for Heart Research (ISHR)-ES. He is the founder of Forcefield Therapeutics and Heqet Therapeutics, which develop biologics for myocardial infarction and heart failure.
